Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |